Advertisement
Letter to the Editor| Volume 88, ISSUE 2, P256-258, November 2017

PLACK syndrome resulting from a new homozygous insertion mutation in CAST

      Inherited abnormalities of proteases or protease inhibitors have been shown to underlie a spectrum of skin barrier genodermatoses that lead to variable degrees of fragility, scaling and inflammation (reviewed in de Veer et al. [
      • de Veer S.J.
      • Furio L.
      • Harris J.M.
      • Hovnanian A.
      Proteases: common culprits in human skin disorders.
      ]). One recent addition to this group is the autosomal recessive disorder, PLACK syndrome (OMIM616295). In 2015, Lin et al. [
      • Lin Z.
      • Zhao J.
      • Nitoiu D.
      • Scott C.A.
      • Plagnol V.
      • Smith F.J.
      • et al.
      Loss-of-function mutations in CAST cause peeling skinleukonychia, acral punctate keratoses, cheilitis, and knuckle pads.
      ] reported homozygous loss-of-function mutations in CAST (encoding calpastatin) in three families from different ethnic backgrounds (Chinese, Nepalese and European). Clinically, the signs comprised peeling skin, leukonychia, acral keratoses, cheilitis, and knuckle pads, hence the derivation of the acronym, PLACK syndrome. Calpastatin is an endogenous specific inhibitor of calpain, a calcium-dependent cysteine protease [
      • Potz B.A.
      • Abid M.R.
      • Sellke F.W.
      Role of calpain in pathogenesis of human disease processes.
      ]. It is expressed in most tissues (except brain) with high expression of CAST noted in stratified squamous epithelia, including skin [
      • Potz B.A.
      • Abid M.R.
      • Sellke F.W.
      Role of calpain in pathogenesis of human disease processes.
      ]. Loss of calpastatin in the affected individuals led to defective keratinocyte adhesion as well as increased keratinocyte apoptosis [
      • Lin Z.
      • Zhao J.
      • Nitoiu D.
      • Scott C.A.
      • Plagnol V.
      • Smith F.J.
      • et al.
      Loss-of-function mutations in CAST cause peeling skinleukonychia, acral punctate keratoses, cheilitis, and knuckle pads.
      ]. Three different homozygous mutations were reported: c.607dup (p.Ile203Asnfs*8), c.424A >T (p.Lys142*), and c.1750delG (p.Val584Trpfs*37) [
      • Lin Z.
      • Zhao J.
      • Nitoiu D.
      • Scott C.A.
      • Plagnol V.
      • Smith F.J.
      • et al.
      Loss-of-function mutations in CAST cause peeling skinleukonychia, acral punctate keratoses, cheilitis, and knuckle pads.
      ]. However, no further reports of PLACK syndrome have been documented thereafter.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • de Veer S.J.
        • Furio L.
        • Harris J.M.
        • Hovnanian A.
        Proteases: common culprits in human skin disorders.
        Trends Mol. Med. 2014; 20: 166-178
        • Lin Z.
        • Zhao J.
        • Nitoiu D.
        • Scott C.A.
        • Plagnol V.
        • Smith F.J.
        • et al.
        Loss-of-function mutations in CAST cause peeling skinleukonychia, acral punctate keratoses, cheilitis, and knuckle pads.
        Am. J. Hum. Genet. 2015; 96: 440-447
        • Potz B.A.
        • Abid M.R.
        • Sellke F.W.
        Role of calpain in pathogenesis of human disease processes.
        J. Nat. Sci. 2016; 2: e218
        • Fine J.D.
        • Bruckner-Tuderman L.
        • Eady R.A.
        • Bauer E.A.
        • Bauer J.W.
        • Has C.
        • et al.
        Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.
        J. Am. Acad. Dermatol. 2014; 70: 1103-1126
        • Goll D.E.
        • Thompson V.F.
        • Li H.
        • Wei W.
        • Cong J.
        The calpain system.
        Physiol. Rev. 2003; 83: 731-801
        • Carragher N.O.
        Calpain inhibition: a therapeutic strategy targeting multiple disease states.
        Curr. Pharm. Des. 2006; 12: 615-638
        • Nakajima R.
        • Takao K.
        • Huang S.M.
        • Takano J.
        • Iwata N.
        • Miyakawa T.
        • et al.
        Comprehensive behavioral phenotyping of calpastatin-knockout mice.
        Mol. Brain. 2008; 1: 7
        • Nassar D.
        • Letavemier E.
        • Baud L.
        • Aractingi S.
        • Khosrotehrani K.
        Calpain activity is essential in skin wound healing and contributes to scar formation.
        PLoS One. 2013; 7: e37084